POET Technologies: A Photonics Pioneer Caught Between a Slashed Forecast and a Reinforced Bench

POET's revenue lags expectations despite 112% growth, but $796M cash and new orders support long-term optical interposer plans.

There's an uncomfortable gap between where POET Technologies wants to be and where its income statement currently sits — and the market has been pricing that distance with brutal precision. The stock has shed more than half its value since touching a 52-week high of EUR 18.84 in May, closing most recently at EUR 6.43. Yet the company's leadership has spent the summer quietly rebuilding the infrastructure needed to make its optical-interposer story credible.

That disconnect — between a deteriorating near-term outlook and a strengthening long-term setup — is the real narrative here.

The Numbers Tell a Two-Sided Story

The most recent quarterly report, filed on August 13, captures the tension perfectly. Revenue came in at $569,925, up 112 percent year over year and 13 percent sequentially — the sixth consecutive quarter of sequential growth. But that figure fell short of the $500,000 target analysts had already set, a bar that was hardly demanding to begin with.

The net loss under US GAAP reached $11.34 million, or $0.07 per share, which at least matched analyst expectations on the bottom line. The top line, however, was a different matter.

Five days after the earnings release, the stock gapped down to open at $8.78 after closing at $9.40, on unusually heavy volume of 2.54 million shares. The market appeared to digest slowly just how far actual revenue remains from the expectations attached to a company carrying such an elevated valuation.

Estimates Slashed, Ambition Intact

That skepticism has now hardened into revised consensus figures. Simply Wall St cut its revenue forecast for the current fiscal year by 59 percent, from $3.48 million to just $1.44 million. The projected loss per share was simultaneously widened to minus $0.32.

For a company positioning itself as a supplier to the next generation of data centers — where AI workloads are straining copper-based connectivity to its limits — that is a sobering reassessment of the near term.

And yet, a meaningful slice of the analyst community remains unwilling to abandon the larger thesis. 24/7 Wall St. issued a "Buy" rating on Friday with a twelve-month price target of $17.74, pointing to a strengthened balance sheet with $796 million in liquid assets and a $50 million order from customer Lumilens. Zacks Investment Research, meanwhile, cited an average short-term price target of $20.25, based on two analyst opinions ranging from $17.50 to $23.00. Both assessments date from Friday, underscoring that the long-term photonics story retains believers who refuse to be rattled by one weak quarter.

A Governance Overhaul With Operational Teeth

The bull case rests partly on personnel moves that began well before the recent earnings disappointment. In May, the company appointed Dr. Sandeep Kumar as Chief Operating Officer — a move that predated the board restructuring by several months and signaled an early focus on scaling operations.

Then, effective August 1, POET reorganized its board of directors. Dr. Bardia Pezeshki and Jean F. Rankin joined the governing body, while long-serving director Jean-Louis Malinge stepped down for personal reasons. The new arrivals bring credentials that map directly onto POET's challenges: Pezeshki, a founder and former CEO or CTO of Avicena Tech, Kaiam, and Santur, has deep experience in optical communications and semiconductor technology — precisely the domain where POET markets its Optical Interposer platform. Rankin contributes governance and legal expertise accumulated across stints at InterDigital, Resonant, LSI, and Agere.

Both received 21,460 restricted stock units vesting through June 2027 — an incentive structure designed for continuity rather than quick exits.

The Balance Sheet Provides Running Room

The financial foundation for the promised production ramp looks firmer than the share price suggests. POET held $796.3 million in cash following the $400 million financing completed in May, giving management room to execute without an imminent return to capital markets. The second-quarter net loss of $11.3 million also marked an improvement from the $12.3 million recorded in the first quarter.

The stock currently trades roughly 12 percent below its 50-day moving average and about 9.0 percent below its 200-day average, with annualized volatility of 96 percent — a figure that captures the nervousness endemic to semiconductor growth names. No single catalyst explains the most recent 2.0 percent daily decline; it reads more as a continuation of consolidation following a twelve-month run that still leaves the stock up 39 percent.

The board's decision not to pursue a relocation to the United States, at least for now, may have added to short-term uncertainty, with some observers interpreting it as strategic hesitation.

What Comes Next

Order backlog has grown to $60 million, including a fresh $2.4 million order for optical 1.6T engines — the technology required for the next generation of data center transmission. Insider ownership sits at just 0.07 percent, with no significant management buying or selling reported over the past three months.

Attention now turns to the ECOC optical conference in Europe, where Senior Vice President Raju Kankupati is scheduled to present an update on September 23 on the production ramp trajectory for 800G and 1.6T engines. The company's own guidance points to entering series production for customer qualifications in 2026.

Whether that presentation will soothe the skeptics or further deflate the optimists remains the open question. What is clear is that POET has spent the summer assembling the operational and governance infrastructure to back its promises — even as the market demands proof that the revenue will eventually follow. The volatility will persist until that evidence arrives. But the foundation, at least on paper, looks more solid than the recent price action suggests.